H.R. 4007 · 118th Congress (2023–2025)
HEAL Act of 2023
This bill requires the Department of Health and Human Services (HHS) to ensure that references in its grant programs to opioid overdose reversal agents are inclusive of any such agents that have been approved by the Food and Drug Administration (FDA).
Specifically, HHS must ensure that regulations, guidance, and other documents for grant programs that include references to opioid overdose reversal agents (e.g., naloxone) encompass any opioid overdose reversal agent that has been approved by the FDA. HHS must also update such references with respect to materials that were previously issued for State Opioid Response Grants, Tribal Opioid Response Grants, and Programs of Regional and National Significance for substance use disorder prevention.
!--tinycomments|2.1|data:application/json;base64,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-->Show official title
To ensure references to opioid overdose reversal agents in grant programs of the Department of Health and Human Services are not limited to naloxone.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 4007’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Kelly Armstrong (R-ND-At Large) (R-ND)
- Cosponsors
9 cosponsors
1 original · 8 later
3 R · 6 D
- Rep. Paul Tonko (D-NY-20)· Original · Jun 12, 2023
- Rep. Brittany Pettersen (D-CO-7)· Later · Jun 21, 2023
- Rep. David J. Trone (D-MD-6)· Later · Jun 30, 2023
- Rep. David P. Joyce (R-OH-14)· Later · Jul 24, 2023
- Rep. Derek Kilmer (D-WA-6)· Later · Jul 26, 2023
- Rep. Don Bacon (R-NE-2)· Later · Aug 4, 2023
- Rep. Ann M. Kuster (D-NH-2)· Later · Aug 11, 2023
- Rep. Michael Lawler (R-NY-17)· Later · Sep 12, 2023
- Rep. Chris Pappas (D-NH-1)· Later · Apr 19, 2024
- Policy area
- Health
- Subjects
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Government information and archives
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jun 12, 2023 – Jun 16, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Jun 21, 2023 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
HEAL Act of 2023
Display title, Short title · Introduced in House
Halting the Epidemic of Addiction and Loss Act of 2023
Short title · Introduced in House
To ensure references to opioid overdose reversal agents in grant programs of the Department of Health and Human Services are not limited to naloxone.
Official title · Introduced in House